Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine?

@article{Kelly1994NeurolepticMS,
  title={Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine?},
  author={Dr. Michael J. Kelly and Sorin J. Brull},
  journal={Canadian journal of anaesthesia = Journal canadien d'anesthesie},
  year={1994},
  volume={41 9},
  pages={
          845-9
        }
}
Neuroleptic malignant syndrome (NMS) and malignant hyperthermia (MH) may have a common pathogenic mechanism; therefore, it has been suggested that known triggering agents for MH (such as succinylcholine) should be avoided in patients with NMS. Electroconvulsive therapy (ECT) continues to play a major therapeutic role in contemporary psychiatry, and succinylcholine has been the muscle relaxant of choice in attenuating violent muscle contractions induced by ECT. Mivacurium is a non-depolarizing… CONTINUE READING
Highly Cited
This paper has 17 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Anesthesia for ECT

View 1 Excerpt
Highly Influenced